Chronic myeloid leukemia: First-line drug of choice
Author:
Affiliation:
1. Department of Leukemia; The University of Texas M. D. Anderson Cancer Center; Houston Texas
Publisher
Wiley
Subject
Hematology
Reference79 articles.
1. The molecular biology of chronic myeloid leukaemia;Melo;Leukemia,1996
2. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia;Shuai;Oncogene,1996
3. The BCR-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation;Raitano;Proc Natl Acad Sci USA,1995
4. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy;Huang;Cancer,2012
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Late presentation of chronic myeloid leukaemia patients in a low-income country: the prognostic implications and impact on treatment outcome;BMC Research Notes;2024-09-03
2. Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers;Clinical and Translational Science;2024-09
3. Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy;Frontiers in Oncology;2024-07-29
4. Late presentation of chronic myeloid leukaemia patients in a low-income country: The prognostic implications and impact on treatment outcome;2024-06-12
5. The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia;Pathology - Research and Practice;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3